Fortis Healthcare Limited — Important, 17-01-2025: Updates

Fortis Healthcare Limited has successfully acquired additional equity shares in Agilus Diagnostics Limited, increasing its total ownership to 89.2%. This acquisition involved purchasing 1,24,37,811 shares from NYLIM Jacob Ballas India Fund III LLC (15.86% stake) and 63,10,315 shares from Resurgence PE Investments Limited (8.05% stake). This follows a prior acquisition of 5,970,149 shares from International Finance Corporation, representing a 7.61% stake. The consolidation of shares from these private equity investors reflects Fortis's strategic intent to solidify its position in Agilus, enhancing its operational control and potential for future growth. Investors should view this as a significant development, indicating a positive outlook for Fortis's expansion strategy in the diagnostics sector.